Patent AnalyticsExaminers
Rankings

Company or institution

LUPIN LIMITED

261 applicationsfiled 2006 to 2026

Allowance rate
52%
−23 pts vs the USPTO range 46% to 58%
Rejections before allowance
1.8
+0.3 vs the USPTO
Months to first action
14.6 mo
−4.0 vs the USPTO
Needed an RCE
27%
level with the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations125 apps
C07D Heterocyclic compounds88 apps
C07K Peptides10 apps
A61M Devices for introducing media into the body9 apps
C07C 6 apps
C07J 5 apps

Art units

162424 apps
162524 apps
161523 apps
162219 apps
162619 apps
161714 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19617042STABLE OPHTHALMIC PHARMACEUTICAL FORMULATION OF AFLIBERCEPT2026-08-20Pending00n/a
19608669Stable Pharmaceutical Compositions of Dalbavancin as Ready-to Dilute Formuation2026-07-23Pending00n/a
19605354PHARMACEUTICAL FORMULATION OF ANTI-IL-5 ANTIBODY2026-07-10Pending00n/a
15361339Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15478891Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15111641Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15741177Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15130739Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15708453Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15884816Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 261 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in